ras gene mutations as a prognostic marker in adenocarcinoma of the human lung without lymph node metastasis.

[1]  S. Steinberg,et al.  ras gene mutations in non-small cell lung cancers are associated with shortened survival irrespective of treatment intent. , 1991, Cancer research.

[2]  K. Kinzler,et al.  Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. , 1991, Science.

[3]  J. Minna,et al.  Mutations of ras genes distinguish a subset of non-small-cell lung cancer cell lines from small-cell lung cancer cell lines. , 1991, Oncogene.

[4]  R. Katakura,et al.  Detection of p53 gene mutations in human brain tumors by single-strand conformation polymorphism analysis of polymerase chain reaction products. , 1991, Oncogene.

[5]  S. Rodenhuis,et al.  Relationship between K-ras oncogene activation and smoking in adenocarcinoma of the human lung. , 1991, Journal of the National Cancer Institute.

[6]  J. Bishop.  Molecular themes in oncogenesis , 1991, Cell.

[7]  C. Marshall.  Tumor suppressor genes , 1991, Cell.

[8]  L. Cantley,et al.  Oncogenes and signal transduction , 1991, Cell.

[9]  J. Minna,et al.  Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer. Lung Cancer Study Group. , 1990, Oncogene.

[10]  S. Rodenhuis,et al.  K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung. , 1990, The New England journal of medicine.

[11]  S. Hirohashi,et al.  Association of point mutation in c‐Ki‐ras oncogene in lung adenocarcinoma with particular reference to cytologic subtypes , 1990, Cancer.

[12]  K. Sugio,et al.  K‐ras activation in colorectal tumors from patients with familial polyposis coli , 1990, Cancer.

[13]  T. Sekiya,et al.  Detection of ras gene mutations in human lung cancers by single-strand conformation polymorphism analysis of polymerase chain reaction products. , 1990, Oncogene.

[14]  J. L. Bos,et al.  ras oncogenes in human cancer: a review. , 1989, Cancer research.

[15]  C. Bartram,et al.  High frequency of Ki‐ras codon 12 mutations in pancreatic adenocarcinomas , 1989, International journal of cancer.

[16]  S. Rodenhuis,et al.  The molecular genetics of human lung cancer. , 1989, The European respiratory journal.

[17]  N. Lemoine,et al.  High frequency of ras oncogene activation in all stages of human thyroid tumorigenesis. , 1989, Oncogene.

[18]  S. Rodenhuis,et al.  Incidence and possible clinical significance of K-ras oncogene activation in adenocarcinoma of the human lung. , 1988, Cancer research.

[19]  Y. Nakamura,et al.  Genetic alterations during colorectal-tumor development. , 1988, The New England journal of medicine.

[20]  K. Sugio,et al.  Differential expression of c-myc gene and c-fos gene in premalignant and malignant tissues from patients with familial polyposis coli. , 1988, Cancer research.

[21]  G. Fleuren,et al.  KRAS codon 12 mutations occur very frequently in pancreatic adenocarcinomas. , 1988, Nucleic acids research.

[22]  M. Sklar.  Increased resistance to cis-diamminedichloroplatinum(II) in NIH 3T3 cells transformed by ras oncogenes. , 1988, Cancer research.

[23]  M. Sklar.  The ras oncogenes increase the intrinsic resistance of NIH 3T3 cells to ionizing radiation. , 1988, Science.

[24]  S. Rodenhuis,et al.  Mutational activation of the K-ras oncogene. A possible pathogenetic factor in adenocarcinoma of the lung. , 1987, The New England journal of medicine.

[25]  H. Mano,et al.  A point mutation at codon 13 of the N-ras oncogene in myelodysplastic syndrome , 1987, Nature.

[26]  C. Mountain,et al.  A new international staging system for lung cancer. , 1987, Chest.

[27]  J. Bos,et al.  A dot-blot screening procedure for mutated ras oncogenes using synthetic oligodeoxynucleotides. , 1986, Gene.

[28]  C. Marshall,et al.  Amino-acid substitutions at codon 13 of the N-ras oncogene in human acute myeloid leukaemia , 1985, Nature.

[29]  A. Zelenetz,et al.  Transformation by subgenomic fragments of Rous sarcoma virus DNA , 1980, Cell.